Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- City of Hope
- Nature Careers
- Harvard University
- Nanyang Technological University
- University of British Columbia
- University of Maryland, Baltimore
- University of Oslo
- IBMC
- Keio University
- Life and Health Sciences Research Institute (ICVS), from the School of Medicine (EM) of the University of Minho
- Northeastern University
- RMIT UNIVERSITY
- RMIT University
- SUNY University at Buffalo
- The Francis Crick Institute;
- The University of British Columbia (UBC)
- UNIVERSITY OF MELBOURNE
- UNIVERSITY OF THE SUNSHINE COAST - UNISC
- Universidad de Cantabria
- Universidade de Coimbra
- University of California, San Francisco
- University of Colorado
- University of Glasgow
- University of Glasgow;
- University of Michigan - Ann Arbor
- University of Sydney
- VIB
- 17 more »
- « less
-
Field
-
Hope. To accelerate the development of new therapies, we leverage City of Hope’s unique in-house GMP manufacturing capabilities for cell therapy (CAR-T cells, stem cells, etc.), monoclonal antibodies
-
therapy, proteomics, and experimental models ranging from human induced pluripotent stem cell (iPSC)-derived retinal neurons to mouse and donated human tissue. You will be part of a dynamic, collaborative
-
Life and Health Sciences Research Institute (ICVS), from the School of Medicine (EM) of the University of Minho | Portugal | about 1 month ago
Multifunctional Electroactive Hydrogels Loaded with Stem Cells Secretome”, with the reference 16471 - NORTE2030-FEDER-00764200, funded by national and European funds through the Foundation for Science and
-
advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community made of people with many skills and talents. We seek candidates whose work
-
from your PhD. Skilled in experimental neurobiology and molecular biology; experience with in vivo models, imaging, or stem cell systems is a plus. Motivated, resilient, and excited to grow as a project
-
000 individuals in UK. As part of a wider strategy to develop a deep human experimental medicines platform, this project aims to mainly focus on using novel human in vitro platforms using IBD gut stem